Comparison 19. Metapex versus zinc oxide eugenol (ZOE) pulpectomy.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Clinical failure | 2 | Risk Ratio (M‐H, Fixed, 95% CI) | Subtotals only | |
1.1 6 months | 2 | 62 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.6 [0.08, 4.29] |
1.2 12 months | 2 | 62 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.71 [0.15, 3.33] |
2 Radiological failure | 2 | Risk Ratio (M‐H, Fixed, 95% CI) | Subtotals only | |
2.1 6 months | 2 | 62 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.0 [0.31, 3.27] |
2.2 12 months | 2 | 62 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.0 [0.31, 3.27] |